1. Home
  2. NAN vs SRDX Comparison

NAN vs SRDX Comparison

Compare NAN & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAN
  • SRDX
  • Stock Information
  • Founded
  • NAN 1999
  • SRDX 1979
  • Country
  • NAN United States
  • SRDX United States
  • Employees
  • NAN N/A
  • SRDX N/A
  • Industry
  • NAN Investment Managers
  • SRDX Medical/Dental Instruments
  • Sector
  • NAN Finance
  • SRDX Health Care
  • Exchange
  • NAN Nasdaq
  • SRDX Nasdaq
  • Market Cap
  • NAN 349.4M
  • SRDX 415.4M
  • IPO Year
  • NAN N/A
  • SRDX 1998
  • Fundamental
  • Price
  • NAN $11.11
  • SRDX $35.81
  • Analyst Decision
  • NAN
  • SRDX Buy
  • Analyst Count
  • NAN 0
  • SRDX 2
  • Target Price
  • NAN N/A
  • SRDX $43.00
  • AVG Volume (30 Days)
  • NAN 74.6K
  • SRDX 193.1K
  • Earning Date
  • NAN 01-01-0001
  • SRDX 08-12-2025
  • Dividend Yield
  • NAN 4.37%
  • SRDX N/A
  • EPS Growth
  • NAN N/A
  • SRDX N/A
  • EPS
  • NAN N/A
  • SRDX N/A
  • Revenue
  • NAN N/A
  • SRDX $121,575,000.00
  • Revenue This Year
  • NAN N/A
  • SRDX N/A
  • Revenue Next Year
  • NAN N/A
  • SRDX $3.19
  • P/E Ratio
  • NAN N/A
  • SRDX N/A
  • Revenue Growth
  • NAN N/A
  • SRDX N/A
  • 52 Week Low
  • NAN $9.11
  • SRDX $26.00
  • 52 Week High
  • NAN $11.34
  • SRDX $41.32
  • Technical
  • Relative Strength Index (RSI)
  • NAN 41.86
  • SRDX 70.99
  • Support Level
  • NAN $10.96
  • SRDX $35.55
  • Resistance Level
  • NAN $11.05
  • SRDX $38.10
  • Average True Range (ATR)
  • NAN 0.09
  • SRDX 1.33
  • MACD
  • NAN -0.01
  • SRDX 0.38
  • Stochastic Oscillator
  • NAN 39.02
  • SRDX 78.15

About NAN Nuveen New York Quality Municipal Income Fund

Nuveen New York Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal, New York State and New York City income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

Share on Social Networks: